×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
上海药物研究所 [6]
四川大学 [2]
上海健康医学院 [2]
山东大学 [1]
中国医学科学院 北京... [1]
长春应用化学研究所 [1]
更多...
内容类型
期刊论文 [13]
发表日期
2018 [1]
2017 [1]
2016 [2]
2015 [1]
2014 [1]
2011 [2]
更多...
学科主题
Pharmacolo... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共13条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI-microangiography-histopathology in rats
期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2018, 卷号: 143, 期号: 7
作者:
Liu, Yewei
;
De Keyzer, Frederik
;
Wang, Yixin
;
Wang, Fengna
;
Feng, Yuanbo
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/12/06
vascular-disrupting agent
combretastatin A4 phosphate
hepatocellular carcinoma
magnetic resonance imaging
rats
Micro-HCCs in rats with liver cirrhosis: paradoxical targeting effects with vascular disrupting agent CA4P
期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 33
作者:
Liu, Yewei
;
Yin, Ting
;
De Keyzer, Frederik
;
Feng, Yuanbo
;
Chen, Feng
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/06
vascular-disrupting agents
combretastatin A4 phosphate
therapeutic response
microcancer
hepatocellular carcinoma
Reverse micelles-in-microspheres with sustained release of water-soluble combretastatin A4 phosphate for S180 tumor treatment
期刊论文
Journal of Materials Chemistry B, 2016, 卷号: Vol.4 No.4, 页码: 760-767
作者:
Wu, L.
;
Qiu, L.
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/02/25
Reverse micelles-in-microspheres with sustained release of water-soluble combretastatin A4 phosphate for S180 tumor treatment
期刊论文
Journal Of Materials Chemistry B, 2016, 卷号: Vol.4 No.4, 页码: 760-767
作者:
Liping wu and Liyan Qiu*
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/03/26
Coadministration of Vascular Disrupting Agents and Nanomedicines to Eradicate Tumors from Peripheral and Central Regions
期刊论文
small, 2015, 卷号: 11, 期号: 31, 页码: 3755-3761
作者:
Song,Wantong
;
Tang,Zhaohui
;
Zhang,Dawei
;
Yu,Haiyang
;
Chen,Xuesi
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2016/05/03
COMBRETASTATIN A4 PHOSPHATE
PEGYLATED LIPOSOMAL DOXORUBICIN
TARGETING AGENT
CANCER-THERAPY
GOLD NANOPARTICLES
CLINICAL-TRIAL
DRUG-DELIVERY
SOLID TUMORS
THERAPEUTICS
PERMEABILITY
A phase I clinical trial assessing the safety and tolerability of combretastatin A4 phosphate injections
期刊论文
2014, 卷号: 25, 期号: 4, 页码: 462-471
作者:
Liu, Peng
;
Qin, Yan
;
Wu, Lingying
;
Yang, Sheng
;
Li, Nan
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2020/01/13
adverse events
combretastatin A4 phosphate
tolerated dose
Effects of the novel vascular targeting agent MDS-11P on tumor vascularity and its antitumor activity
期刊论文
BIOCHEMICAL PHARMACOLOGY, 2011, 卷号: 82, 期号: 12, 页码: 1832-1842
作者:
Deng, Zhi-Ting
;
Feng, Teng
;
Wang, Peng
;
Qi, Xin
;
Chen, Xue-Hong
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/01/08
Vascular disrupting agents
MDS-11P
Antitumor
CA4 derivative
Vascularity
MT119, a new planar-structured compound, targets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation
期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2011, 卷号: 129, 期号: 1, 页码: 214-224
作者:
Zhang, Zhixiang
;
Meng, Tao
;
Yang, Na
;
Wang, Wei
;
Xiong, Bing
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/01/08
mitosis
tubulin
the colchicine site
spindle assembly
1,4-Diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) Enhances the Cytotoxicity of Combretastatin A4 Independently of Mitogen-Activated Protein Kinase Kinase
期刊论文
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 卷号: 330, 期号: 1, 页码: 326-333
作者:
Quan, Haitian
;
Liu, Houfu
;
Li, Chuan
;
Lou, Liguang
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/01/08
©版权所有 ©2017 CSpace - Powered by
CSpace